Arrhythmogenic Cardiomyopathy: what blood can reveal?

Blood, serum and plasma represent accessible sources of data about physiological and pathological status. In Arrhythmogenic Cardiomyopathy (ACM), circulating nucleated cells are routinely employed for detection of germinal genetic mutations. In addition, different biomarkers have been proposed for diagnostic purposes and for monitoring disease progression, and these include inflammatory cytokines, markers of myocardial dysfunction and damage, microRNAs. This review summarizes the current information that can be retrieved from the blood of ACM patients and consider the future prospects.
Source: Heart Rhythm - Category: Cardiology Authors: Source Type: research